Here is the latest stock price and chart of CIPLA. For more details, see the CIPLA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since large caps interest you, here's our guide to buying bluechip stocks.
Latest: Richa Agarwal's Top 3 Stocks for 2022 Revealed
Live BSE Quotes | May 17, 2022 01:26:00 PM | ||
---|---|---|---|
Price (Rs)927.90 | Open (Rs) 930.10 | High (Rs) 934.95 | Low (Rs) 916.30 |
% Change-0.56 | Volume 39,361 | Value (Rs) 36,523,072 | 52-Week H/L 1,083.15 / 850.00 |
Live NSE Quotes | May 17, 2022 1:29:59 PM | ||
---|---|---|---|
Price (Rs)928.15 | Open (Rs) 935.00 | High (Rs) 935.35 | Low (Rs) 916.20 |
% Change-0.56 | Volume 1,389,845 | Value (Rs) 1,282,062,520 | 52-Week H/L 1,083.00 / 850.00 |
Change | |||||
---|---|---|---|---|---|
1 Day -0.56% | 1 Month -9.66% | 3 Months 0.01% | 1 Year 5.32% | 5 Years (CAGR)* 10.66% | 10 Years (CAGR)* 11.45% |
* Compound Annual Growth Rate
Valuation | ||||
---|---|---|---|---|
EPS (Rs)* 32.20 | P/E Ratio (x) 28.81 | Market Cap (Rs m) 748,642.71 | P/BV (x) 4.09 | Dividend Yield (%) 0.54 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
CIPLA last traded price was down 0.6% to Rs 927.9 on the BSE. On the NSE, CIPLA last traded price was down 0.6% to Rs 928.2. The total volume of shares traded was 1.4 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 0.7%. And the benchmark S&P BSE SENSEX was at 53,887.5 (up 1.7%).
Over the last 30 days, the CIPLA share price is down 8.7%. And over the last one year, CIPLA share price is up 2.6%.
The current market capitalisation of CIPLA stands at Rs 748,642.71 m. For more information, check out the list of top 100 companies in India in terms of market cap.
As of March 2022, company promoters held 33.63% stake in CIPLA, with no shares having been pledged. To know more, check out the latest shareholding pattern of CIPLA.
What else is happening in the markets today? Dig in...
Share markets in India have extended early gains and are presently trading on a strong note.
The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?
As the new variant of Covid-19 emerges, keep an eye on these stocks.
These companies are likely to benefit the most from Covid-19 vaccines.
For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.
The strong momentum in India's IPO market is poised to continue with the market regulator approving the IPOs of three firms including PharmEasy.
More Views on NewsWe are just two months into 2022 and several penny stocks that we track have already surged 5x.
Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.
A step-by-step method to pick the best penny stocks for the long term.
These penny stocks can become future multibaggers. Watch out for them.
Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?
More